Previous studies demonstrate that intrastriatal injections of fibrillar alpha-synuclein (α-syn) into mice induce Parkinson's disease (PD)-like Lewy body (LB) pathology formed by aggregated α-syn in anatomically interconnected regions and significant nigrostriatal degeneration. The aim of the current study was to evaluate whether exogenous mouse α-syn pre-formed fibrils (PFF) injected into the striatum of rats would result in accumulation of LB-like intracellular inclusions and nigrostriatal degeneration. Sprague-Dawley rats received unilateral intrastriatal injections of either non-fibrillized recombinant α-syn or PFF mouse α-syn in 1-or 2-sites and were euthanized at 30, 60 or 180 days post-injection (pi). Both non-fibrillized recombinant α-syn and PFF α-syn injections resulted in phosphorylated α-syn intraneuronal accumulations (i.e., diffuse Lewy neurite (LN)-and LB-like inclusions) with significantly greater accumulations following PFF injection. LB-like inclusions were observed in several areas that innervate the striatum, most prominently the frontal and insular cortices, the amygdala, and the substantia nigra pars compacta (SNpc). α-Syn accumulations co-localized with ubiquitin, p62, and were thioflavin-S-positive and proteinase-k resistant, suggesting that PFF-induced pathology exhibits properties similar to human LBs. Although α-syn inclusions within the SNpc remained ipsilateral to striatal injection, we observed bilateral reductions in nigral dopamine neurons at the 180-day time-point in both the 1-and 2-site PFF injection paradigms. PFF injected rats exhibited bilateral reductions in striatal dopaminergic innervation at 60 and 180 days and bilateral decreases in homovanillic acid; however, dopamine reduction was observed only in the striatum ipsilateral to PFF injection. Although the level of dopamine asymmetry in PFF injected rats at 180 days was insufficient to elicit motor deficits in amphetamine-induced rotations or forelimb use in the cylinder task, significant disruption of ultrasonic vocalizations was observed. Taken together, our findings demonstrate that α-syn PFF are sufficient to seed the pathological conversion and propagation of endogenous α-syn to induce a progressive, neurodegenerative model of α-synucleinopathy in rats.
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Introduction
Parkinson's disease (PD) pathology is characterized by the formation of intraneuronal Lewy body (LB) and Lewy neurite (LN) inclusions which are composed primarily of misfolded, fibrillar α-synuclein (α-syn) (Goedert, 2001) . α-syn is a 140-amino acid protein that adopts a α-helical structure when bound to membranes; however, it can easily fold into a β-sheet-rich structure that polymerizes into fibrils and aggregates (Stefanis, 2012) . Duplication, triplication or genetic mutations in the α-syn gene (A53T, A30P, E46K, G51D, etc.) are linked to autosomal dominant PD; thus implicating its role in the pathogenesis of PD (Kiely et al., 2013; Polymeropoulos et al., 1997; Kruger et al., 1998; Zarranz et al., 2004) . Moreover, these mutations affect α-syn amyloid fibril formation in vitro by either accelerating the formation of fibrils (Conway et al., 1998) or by making them unstable and easier to propagate than wild-type (WT) fibrils (Yonetani et al., 2009) . Taken together, these data suggest that the rate of fibril formation and propagation (gradual, systematic spread) is an important factor involved in the disease process.
Mounting evidence suggests that pathological forms of α-syn selfpropagate and spread progressively throughout interconnected brain Neurobiology of Disease 82 (2015) 185-199 
